ANIX Anixa Biosciences Inc
Company Analysis
Latest News
🟢 Anixa Biosciences is trading 5.19% up today after positive breast-cancer vaccine Phase 1 data
Anixa Biosciences is trading 5.19% up at $2.73 after positive breast-cancer vaccine Phase 1 data. - The company is advancing its breast-cancer vaccine toward...
🟢 Anixa Biosciences is trading 8% up in pre-market after positive breast-cancer vaccine Phase 1 data
Anixa Biosciences is trading 7.69% higher at $2.80 after positive breast-cancer vaccine Phase 1 data, survival observations from its ovarian-cancer CAR-T...
Anixa's Cancer Data Sparks a 7% Rally, but Can a $100 Million Biotech Survive the Long Road to Phase 2?
Shares of Anixa Biosciences jumped 7.3% to $2.79 on September 16 after the tiny cancer-focused biotech dropped a batch of positive clinical updates and a...
🟢 Anixa Biosciences is trading 7.31% up in after-hours trading after positive breast cancer vaccine data
Anixa Biosciences is trading 7.31% up in after-hours trading at $2.79 following positive breast cancer vaccine Phase 1 data and encouraging survival...
🟢 Anixa Biosciences is trading 6.88% up in after-hours trading after encouraging early cancer-program data
Anixa Biosciences is trading 6.88% up in after-hours trading at $2.95 after September 11, 2026, presentations highlighted encouraging early data from its...
Anixa's Nasdaq Summit Pitch Lifts Shares 7% — But Can a Conference Presentation Move the Needle for a $100M Biotech With No Revenue?
Shares of Anixa Biosciences jumped 7.3% to $3.11 on Sept. 9, bucking a weak broader market, as investors positioned ahead of CEO Amit Kumar's afternoon...
🟢 Anixa Biosciences is trading 7.34% up in pre-market ahead of September 9 clinical-program presentation
Anixa Biosciences is trading 7.34% up now at $3.11 after announcing a September 9 presentation at the Nasdaq & LD Micro Inaugural SF Summit. - Management is...
🔴 Anixa Biosciences is trading 5.2% down today as oil prices and geopolitical tensions pressure equities
Anixa Biosciences is trading 5.2% down at $2.91 amid a weaker September 8, 2026 market. - The S&P 500 is down 0.59% and the Dow is down 1.18%, as rising oil...
🟢 Anixa Biosciences is trading 7.6% up in pre-market; no definitive catalyst identified
Anixa Biosciences is trading 7.6% up at $3.30, rebounding from the September 4, 2026 close of $3.07 after a prolonged decline. - No definitive...
Anixa Biosciences Inc Q3 2026 Earnings Preview: What Analysts Expect on September 09, 2026
For the third quarter of 2026, analysts expect Anixa Biosciences to report zero revenue and a net loss of $0.08 per share, with the current $3.07 share price...
🟢 Anixa Biosciences is trading 7.71% up in after-hours trading after updated lira-cel survival observations
Anixa Biosciences is trading 7.71% up at $3.31 in after-hours trading after updated survival observations from its ongoing Phase 1 lira-cel ovarian-cancer...
🟢 Anixa Biosciences is trading 10.81% up in pre-market after updated Phase 1 ovarian-cancer CAR-T survival observations
Anixa Biosciences is trading 10.81% up now at $3.38 after highlighting updated survival observations from its ongoing Phase 1 ovarian-cancer CAR-T trial. -...
Anixa's Cancer Patients Are Outliving Expectations — But Can a Micro-Cap Biotech Turn Survival Data Into Shareholder Value?
Shares of Anixa Biosciences surged 9.8% to $3.35 after the company highlighted updated survival data from its early-stage ovarian cancer trial — a notable...
🟢 Anixa Biosciences is trading 9.84% up in after-hours trading after positive lira-cel ovarian-cancer CAR-T survival update
Anixa Biosciences is trading 9.84% up at $3.35 after reporting updated positive survival observations from its ongoing Phase 1 lira-cel ovarian-cancer CAR-T...
🟢 Anixa Biosciences is trading 5% up in pre-market
Anixa Biosciences is trading 5.11% up at $3.29 versus the September 2, 2026 close of $3.13; no verified catalyst has been identified. - The latest company...
🟢 Anixa Biosciences is trading 6.07% up in after-hours trading; no verified catalyst identified
Anixa Biosciences is trading 6.07% up at $3.32 after closing at $3.13 on September 2, 2026, with the catalyst unclear. - Searches found no verified...
🟢 Anixa Biosciences is trading 10.37% up in pre-market on September 2, 2026; no clear catalyst identified
Anixa Biosciences is trading 10.37% up in pre-market at $3.62, with no clear company-specific catalyst identified. - The stock closed at $3.28 on September 1,...
🟢 Anixa Biosciences is trading 7.32% up in after-hours trading — no clear company-specific catalyst identified
Anixa Biosciences is trading 7.32% up at $3.52 after closing at $3.28 on September 1, 2026, with no clear company-specific announcement, earnings release, or...
🟢 Anixa Biosciences is trading 8% up in pre-market despite no clear company-specific news
Anixa Biosciences is trading 8% higher at $3.62, up from the August 31 close of $3.35, with no clear company-specific announcement or overnight filing...
🟢 Anixa Biosciences is trading 6% up in after-hours trading with no confirmed company-specific catalyst
Anixa Biosciences is trading 6.03% up now at $3.69 in after-hours trading after closing at $3.48 on August 28, 2026, with no confirmed company-specific...